Blood PressureNCT05482035
Clinical Trial of Wrist Blood Pressure Monitor in Conformance With the EN ISO 81060-2:2019/A1:2020 Standard
A study testing wrist blood pressure monitor in people with Blood Pressure, run by Huawei Device Co., Ltd at 1 site in China.
Trial summary
The accuracy and safety of wrist blood pressure (model: MLY-B10) is evaluated according to the requirement of EN ISO 81060-2:2019/A1:2020. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Blood Pressure
- What is being tested?
- wrist blood pressure monitor
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 88 participants
- Where
- 1 siteChina
- Study dates
- 16 Feb 2022to 31 Mar 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Subjects should voluntarily participate in the clinical trial and sign the informed consent form.
- Subjects must be willing and able to follow the investigation procedures.
- Subjects are over 18 years old whose wrist circumference should be within 13.0-20.0 cm.
Who cannot join
- Subjects with serious arrhythmias (atrial fibrillation, atrial flutter, ventricular flutter, ventricular fibrillation, ventricular tachycardia, borderline tachycardia, sinus arrest, pathological sinus syndrome, pacemaker rhythm) showed by electrocardiogram during screening period.
- Subject with prior allergy to nylon, fluororubber, thermoplastic polyurethane elastomer (TPU), or polyvinyl chloride (PVC) materials.
- Subjects with prior arterial obstructive disease or arteritis.
- Subjects who had previously undergone mastectomy.
- Subjects with wound or wrist inflammation were measured.
- Subjects who are receiving intravenous infusion, blood transfusion, or other catheters at the site of measurement.
Show all 9Show fewer
- Subjects who had eaten, drank, smoked or exercised vigorously in the 30 minutes prior to the study.
- Subjects who have participated in other clinical trials within 30 days that may affect this trial.
- Subjects who the investigator consider inappropriate to attend the trial.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Clinical Trial on the Effectiveness of Blood Pressure Function of Wrist Blood Pressure Monitor
The accuracy and safety of wrist blood pressure (model: MLY-B10) is evaluated according to the requirement of EN ISO 81060-2:2019/A1:2020.
- Conditions
- Blood Pressure
- Being tested
- wrist blood pressure monitor
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
wrist blood pressure monitorDevice
Comparing blood pressure measured by wrist blood pressure monitor with mercury sphygmomanometer .
| Study group | Role | What they receive |
|---|---|---|
| Blood pressure measured by wrist blood pressure monitor and mercury sphygmomanometer | Experimental | Not described Receives: Device: wrist blood pressure monitor |
What is being measured
The primary outcome is the main question the study is designed to answer.
mean difference of systolic blood pressure
mean difference of systolic blood pressure between wrist blood pressure monitor and mercury sphygmomanometer
Measured: 30 minutes
mean difference of diastolic blood pressure
mean difference of diastolic blood pressure between wrist blood pressure monitor and mercury sphygmomanometer
Measured: 30 minutes
standard deviation of the difference of systolic blood pressure
standard deviation of the difference of systolic blood pressure between wrist blood pressure monitor and mercury sphygmomanometer
Measured: 30 minutes
standard deviation of the difference of diastolic blood pressure
standard deviation of the difference of diastolic blood pressure between wrist blood pressure monitor and mercury sphygmomanometer
Measured: 30 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Aug 2022
- Study start16 Feb 2022
- Primary completion31 Mar 2022
- Study completion31 Mar 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Blood PressureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 88 participants (actual)
Sponsor and investigators
- Lead sponsor
- Huawei Device Co., Ltd
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05482035
- Sponsor's protocol ID
- CTP-YBN2021075026A2
- Status last verified
- Jul 2022
- First submitted
- 28 Jul 2022
- Last updated
- 1 Aug 2022
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Aug 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical Trial on the Effectiveness of Blood Pressure Function of Wrist Blood Pressure Monitor
- ClinicalTrials.gov ID
- NCT05482035
- Acronym / sponsor ID
- CTP-YBN2021075026A2
- Conditions
- Blood Pressure
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 88 participants (actual)
- Lead sponsor
- Huawei Device Co., LtdIndustry (pharma, biotech, devices)
- Study start
- 16 Feb 2022 (actual)
- Primary completion
- 31 Mar 2022 (actual)
- Study completion
- 31 Mar 2022 (actual)
- First posted
- 1 Aug 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The accuracy and safety of wrist blood pressure (model: MLY-B10) is evaluated according to the requirement of EN ISO 81060-2:2019/A1:2020.
Study design
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Blood pressure measured by wrist blood pressure monitor and mercury sphygmomanometer | Experimental | Device: wrist blood pressure monitor |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Subjects should voluntarily participate in the clinical trial and sign the informed consent form.
- Subjects must be willing and able to follow the investigation procedures.
- Subjects are over 18 years old whose wrist circumference should be within 13.0-20.0 cm.
Key exclusion criteria (9 listed)
- Subjects with serious arrhythmias (atrial fibrillation, atrial flutter, ventricular flutter, ventricular fibrillation, ventricular tachycardia, borderline tachycardia, sinus arrest, pathological sinus syndrome, pacemaker rhythm) showed by electrocardiogram during screening period.
- Subject with prior allergy to nylon, fluororubber, thermoplastic polyurethane elastomer (TPU), or polyvinyl chloride (PVC) materials.
- Subjects with prior arterial obstructive disease or arteritis.
- Subjects who had previously undergone mastectomy.
- Subjects with wound or wrist inflammation were measured.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| wrist blood pressure monitorComparing blood pressure measured by wrist blood pressure monitor with mercury sphygmomanometer . | Device | Blood pressure measured by wrist blood pressure monitor and mercury sphygmomanometer |
Primary outcome
mean difference of systolic blood pressure
Time frame: 30 minutes
mean difference of systolic blood pressure between wrist blood pressure monitor and mercury sphygmomanometer
mean difference of diastolic blood pressure
Time frame: 30 minutes
mean difference of diastolic blood pressure between wrist blood pressure monitor and mercury sphygmomanometer
standard deviation of the difference of systolic blood pressure
Time frame: 30 minutes
standard deviation of the difference of systolic blood pressure between wrist blood pressure monitor and mercury sphygmomanometer
standard deviation of the difference of diastolic blood pressure
Time frame: 30 minutes
standard deviation of the difference of diastolic blood pressure between wrist blood pressure monitor and mercury sphygmomanometer
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Aug 2022.
Related trials for Blood Pressure
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
RecruitingPhase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
Recruiting
Guiding Optimal Blood Pressure Management in Peritoneal Dialysis Pilot Trial
End Stage Kidney Disease (ESKD), Hypertension (HTN)
RecruitingPhase 4
Hematological Safety of Dipyrone Versus Paracetamol After Dental Extractions
Hematologic Test, Agranulocytosis
Not yet recruiting
Acute Effects of Mat Pilates on Blood Pressure Response to Mental Stress in Higher Education Teachers
Behavior
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing wrist blood pressure monitor in people with Blood Pressure, run by Huawei Device Co., Ltd at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
mean difference of systolic blood pressure (time frame: 30 minutes). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Aug 2022.